Chip Baird

Chip Baird currently serves as the Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer at 2seventy bio, an immuno-oncology cell therapy company that was established in November 2021. In addition to these roles, Chip Baird is the Chairman of the Board of Directors at Deep Genomics and a Board Member at Axcella. Previously, Chip Baird held the position of Chief Financial Officer at bluebird bio, where responsibilities included overseeing finance and compliance functions, and served as Chief Financial Officer at Amicus Therapeutics and PTC Therapeutics, contributing to significant fundraising efforts. Chip Baird's career began as an Underwriter at First Union National Bank and was followed by a role as Engagement Manager at L.E.K. Consulting. Academic qualifications include an MBA in Finance from The Wharton School and a BSFS in International Affairs from Georgetown University.